Replies to post #57985 on Progressive Care Inc (fka RXMD)

[Wangenstein]

AUDIT SHOWED DOUBLE-DIGIT YOY GROWTH MONTH AFTER MONTH

I don't need a lot of words or fancy colors to say that RXMD has had double-digit YoY revenue growth each month for the past year, up to and including March 2017.

I don't need 37 Technicolor paragraphs to know you don't divide $22 million by four to get RXMD's quarterly revenue expectations, particularly when RXMD hasn't earned more than 23% of their annual revenue in Q1 in the past three years, and that in 2016 it was only 21%.

I don't need TO TYPE IN ALL CAPS to write what I know, that RXMD is growing, month after month, year after year; that the third-party-audited financials proved that RXMD's growth is real; and that we'll be seeing RXMD continue to grow for months and years to come.

I don't need BOLD TITLES to show that RXMD's 2015 revenues were up 21% over 2014; that 2016's revenues were up 34% over 2015; or that Q1 2017 is on-track for RXMD to achieve its revenue goal of 20% YoY growth at $22 million.

I don't need any of those things to know that at current revenues, RXMD should be trading at 5-7 cents right now, and will be sooner rather than later.

RXMD is a company that is growing, and a stock to buy and hold.

It's as simple as that.

[Spider Web]

DILUTIVE FINANCING NEXT


TWO TYPES OF REVENUE
1) Pharmacy Prescriptions
2) Other Services


OTHER SERVICES INCLUDE
1) Non-Prescription Items
2) Smart Medical Alliance (SMA)
3) Mgmt Serv Org (MSO) Contracts
SMA & MSO Started In Oct 2016


HOW WILL THIS PLAY OUT
Since the Prescription part of the
business has Topped-Out, and now
showing signs of Contraction, they
need to add another "Growth Story"
to their menu.

So, even though the Service Business
is a Very Small part of the Revenue, they
can still "Talk-Up" its Growth Percentages.
Just like some other things that have been
recently "Talked-Up", with no real results.
Trying to make it sound like Great Potential.
As they lure in some more Equity Financing
and Dilution. Followed by a Reverse-Split.


FOR EXAMPLE
Service Business might have increased
580% over Q1 2016, & 47% Over Q4 2016.
WOW ! ... But Not As Good As It Sounds
And if Q1 2017 Total Rev equals $4.9M,
Service will only be about $36K of that.
ONLY 0.7% OF TOTAL Q1 REVENUE
And that's only if they hit my estimate !

Service is a Very Small percentage
of the business now. And that was
only 0.25% of the Total 2016 Revenue.
ONLY $46K OF THE TOTAL $18.3M
I predict that Q1 of 2017 should almost
equal all of 2016's Service Revenue.
That sounds good, percentage wise.
But a Very Low Percent of the Total.


THE OTHER STUFF
The Audit Was For Financing Purposes Only
They will always keep dangling the Audit and
Uplist Carrot, as well as Out-Of-State Licenses.
They want some to think these are possibilities.
But Everything Is Always Possible... Right ?
However, In Reality... Not So Much


THE REAL GAME PLAN
It Is To Always Keep "Something" In The Loop
But the most this Company can hope, is to get
more money through Dilutive Equity Financing.
Hopefully start a Satellite Location in Florida.

But everything is being shrunk down to the use
of Virtual Pharmacy Modules, for virtual on-site
access to live Pharmacy Staff for assistance &
consultation. Outlined in the MOU with MDFlow.
The Other Stuff? Just Possible Illusions


THAT'S WHAT IT IS


JMO

[gedi8]

You really have it all wrong. If you do a little DD you will discover that the company has double digit growth year over year. The company has licenses in 11 states, the company has partnered up with several entities, the company is on track for 22 million dollars in revenue this year. I can go on if you like.

to summarize, your continued claim of contraction is not worth the paper it's written on.

[Spider Web]

DILUTIVE FINANCING NEXT


TWO TYPES OF REVENUE
1) Pharmacy Prescriptions
2) Other Services


OTHER SERVICES INCLUDE
1) Non-Prescription Items
2) Smart Medical Alliance (SMA)
3) Mgmt Serv Org (MSO) Contracts
SMA & MSO Started In Oct 2016


HOW WILL THIS PLAY OUT
Since the Prescription part of the
business has Topped-Out, and now
showing signs of Contraction, they
need to add another "Growth Story"
to their menu.

So, even though the Service Business
is a Very Small part of the Revenue, they
can still "Talk-Up" its Growth Percentages.
Just like some other things that have been
recently "Talked-Up", with no real results.
Trying to make it sound like Great Potential.
As they lure in some more Equity Financing
and Dilution. Followed by a Reverse-Split.


FOR EXAMPLE
Service Business might have increased
580% over Q1 2016, & 47% Over Q4 2016.
WOW ! ... But Not As Good As It Sounds
And if Q1 2017 Total Rev equals $4.9M,
Service will only be about $36K of that.
ONLY 0.7% OF TOTAL Q1 REVENUE
And that's only if they hit my estimate !

Service is a Very Small percentage
of the business now. And that was
only 0.25% of the Total 2016 Revenue.
ONLY $46K OF THE TOTAL $18.3M
I predict that Q1 of 2017 should almost
equal all of 2016's Service Revenue.
That sounds good, percentage wise.
But a Very Low Percent of the Total.


THE OTHER STUFF
The Audit Was For Financing Purposes Only
They will always keep dangling the Audit and
Uplist Carrot, as well as Out-Of-State Licenses.
They want some to think these are possibilities.
But Everything Is Always Possible... Right ?
However, In Reality... Not So Much


THE REAL GAME PLAN
It Is To Always Keep "Something" In The Loop
But the most this Company can hope, is to get
more money through Dilutive Equity Financing.
Hopefully start a Satellite Location in Florida.

But everything is being shrunk down to the use
of Virtual Pharmacy Modules, for virtual on-site
access to live Pharmacy Staff for assistance &
consultation. Outlined in the MOU with MDFlow.
The Other Stuff? Just Possible Illusions


THAT'S WHAT IT IS


JMO